Achin Gupta has been Chief Executive Officer of Cipla India Business since August 2021. He spearheads Cipla’s One India strategy, leveraging synergies across prescription, generics, and consumer health business.
Achin holds an M Tech degree from IIT Delhi, specializing in Biochemical Engineering and Biotechnology, and an MBA from IIM, Ahmedabad. In over two decades of his career, Achin has built a strong track record as an entrepreneurial leader, establishing new businesses across markets in India, Europe, and emerging markets.
Prior to joining Cipla, he was associated with Glenmark Pharmaceuticals as EVP Business Head EMEA L. Achin was a Member of the Core Operating Group, Director on the Board of key European affiliates, and a Member of Board at Medicines for Europe. In his earlier roles, Achin has worked for Abbott EPD and started his career with a management consulting firm AT Kearney. In addition to being an accomplished commercial leader, he brings an in-depth understanding of cross-functional areas including strategy, portfolio, product development, licensing, and partnerships.
Current role